In a major setback to drug maker Johnson & Johnson, the US Food and Drug Administration has rejected its drug application for a third time. The firm has sought permission from the agency to expand use of the blood thinner Xarelto to reduce dangerous blood clots and related problems in patients with coronary artery disease. But much to the disappointment for the company, the FDA rejected its … [Read more...]
You are here: Home / Archives for Xarelto